04/19/2011 - 12:18pm

U.S. spending on drugs grew 2.3% to $307.4 billion in 2010, according to a new report by the IMS Institute for Healthcare Informatics, part of industry research firm IMS Health.

04/19/2011 - 11:25am

Drug maker Forest Labs has acquired worldwide rights to a drug developed by Procter & Gamble Pharmaceuticals for treating arrhythmia.

04/19/2011 - 10:16am

The Food and Drug Administration has given approval to Sigma-Tau Pharmaceuticals to manufacture the main ingredient of a treatment for leukemia, the drug maker said.

04/18/2011 - 4:08pm

At the upcoming 2011 Armada Specialty Pharmacy Summit in Las Vegas, Amber Pharmacy president Mike Agostino — recently appointed to the Board of Advisors of Specialty Pharmacy — will give a presentation focused on the specialty pharmacy marketplace and the importance of customers. Specialty Pharmacy had the chance to talk with Agostino about the contents of his presentation and his new role.

04/18/2011 - 4:01pm

Healthcare is one of the fastest-growing segments of the American economy right now, and specialty pharmacy is no exception, especially as more baby boomers retire and as drug companies develop more sophisticated therapies.
But by growing, specialty pharmacy can add value to local economies, too. Specialty Pharmacy caught up with Diplomat president and CEO Phil Hagerman to talk about the company's growth strategies.

04/18/2011 - 10:04am

The Food and Drug Administration has approved a drug made by Genentech for treating a rare and severe form of arthritis that affects children, Genentech said.

04/14/2011 - 11:57am

CVS Caremark has unveiled a new medical benefit drug management service for its pharmacy benefit manager and specialty pharmacy clients.

04/14/2011 - 11:49am

Despite a difficult economy and rising health costs, the benefits of an integrated pharmacy service were evident as CVS Caremark helped its pharmacy benefit manager clients — employers, health plans and third-party administrators — manage pharmacy costs, according to the company's annual "Insights Report."

04/13/2011 - 1:56pm

A Food and Drug Administration expert panel has given a favorable vote to a drug made by Pfizer for tumors, Pfizer said Tuesday.